The Future of Sentinel Node Oriented Tailored Approach in Patients with Early Gastric Cancer by Ryu, Keun Won
Editorial
The Future of Sentinel Node Oriented Tailored Approach  
in Patients with Early Gastric Cancer
Keun Won Ryu 
Gastric Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang, Korea
J Gastric Cancer 2012;12(1):1-2  http://dx.doi.org/10.5230/jgc.2012.12.1.1
Correspondence to: Keun Won Ryu
Gastric Cancer Branch, Research Institute and Hospital, National 
Cancer Center, 809, Madu 1-dong, Ilsandong-gu, Goyang 410-769, 
Korea
Tel: +82-31-920-1628, Fax: +82-31-920-0069
E-mail: docryu@korea.com
Received March 5, 2012
Revised March 7, 2012
Accepted March 7, 2012
Copyrights © 2012 by The Korean Gastric Cancer Association www.jgc-online.org
 This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/
licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
After the introduction of sentinel node biopsy (SNB) concept 
in early gastric cancer (EGC) more than decade, it is not yet a 
practically acceptable procedure in the same manner as breast 
cancer or melanoma.(1-3) In this issue, Dr. Miyashiro critically 
reviewed the practical problem and current status of SNB in 
EGC and suggested more sophisticated methods.(4) The debating 
points made in this review article by Dr. Miyashiro is that which is 
commonly accepted by the consensus of the surgical society. For 
the optimistic future of SNB in EGC, several ideas need be shared 
with researchers throughout the world. 
The first consideration is that the protocol of SNB should be 
universally applicable. A highly standardized protocol of surgical 
procedure and pathologic evaluation cannot be adopted in all 
institutions, even with the satisfactory accuracy of SNB. The 
protocol, which can be done only by a specialized center, is not 
ideal and we should develop a more practical method that can be 
performed by a wider range of institutions.(5) 
The second consideration is that the end goal of SNB in 
EGC surgery is the preservation of organ and its function by 
minimizing lymph node dissection (LND). In contrast, SNB in 
breast cancer and melanoma is performed to prevent lymphedema 
by minimizing LND. In the context of SNB, the pick-up method 
is more appropriate rather than the basin dissection. However, the 
pick-up method is somewhat limited in terms of sensitivity in 
EGC. If we can accurately diagnose the lymph node metastasis and 
the organ and function preserving surgery by basin dissection, it is 
the alternative method of pick-up method. In the era of minimally 
invasive surgery, most of EGC is now operated with laparoscopic 
surgery and the difficulty of pick up biopsy by laparoscopy should 
also be considered.(6,7) 
The third consideration is the issue of the qualifying involved 
surgeon, endoscopist, pathologist and institution. The qualification 
is usually estimated by case number of practice, which serves as a 
representative of the learning curve.(8) However, the qualification 
cannot not be estimated merely by the case number because 
personal and institutional learning curves are different each other 
and should be measured by somewhat objective protocol.
After two multicenter trials of SNB in Japan, we have invaluable 
lessons and can prepare for the prevention against defects and 
problems.(4,9,10) For the confirmation of clinical applicability of 
SNB in EGC, multicenter phase III trial should be mandatory. 
Recently, Korean surgical societies are now preparing trials of 
sentinel node oriented tailored approach (SENORITA trial) 
comparing the conventional laparoscopic gastrectomy versus 
laparoscopic SNB, with the organ and function preserving surgery 
of EGC. Before the randomized controlled trial, a qualification 
study of participating institutions will be done by measuring the 
completion of each critical step of SNB protocol.(11) 
Several practical obstacles should be corrected by the evidence-
based approach for the optimistic future of SNB. For an improved 
quality of life in the long-term surviving EGC patient, organ 
and function preserving surgery is essential and indispensible by 
applying SNB in the future.Ryu KW
2
Acknowledgments
This work was supported by the Nation Cancer Center, Republic 
of Korea (grant no. 1110550).
References
1.	Ryu	KW,	Eom	BW,	Nam	BH,	Lee	JH,	Kook	MC,	Choi	IJ,	et	
al.	Is	the	sentinel	node	biopsy	clinically	applicable	for	limited	
lymphadenectomy	and	modified	gastric	resection	in	gastric	
cancer?	A	meta-analysis	of	feasibility	studies.	J	Surg	Oncol	
2011;104:578-584.	
2.	Wang	Z,	Dong	ZY,	Chen	JQ,	Liu	JL.	Diagnostic	value	of	senti-
nel	lymph	node	biopsy	in	gastric	cancer:	a	meta-analysis.	Ann	
Surg	Oncol	2011	Nov	3.	[Epub	ahead	of	print]
3.	Lips	DJ,	Schutte	HW,	van	der	Linden	RL,	Dassen	AE,	Voogd	
AC,	Bosscha	K.	Sentinel	lymph	node	biopsy	to	direct	treat-
ment	in	gastric	cancer.	A	systematic	review	of	the	literature.	
Eur	J	Surg	Oncol	2011;37:655-661.	
4.	Miyashiro	I.	What	is	the	problem	in	clinical	application	of	sen-
tinel	node	concept	to	gastric	cancer	surgery?	J	Gastric	Cancer	
2012;12:7-12.
5.	Aikou	T,	Kitagawa	Y,	Kitajima	M,	Uenosono	Y,	Bilchik	AJ,	
Martinez	SR,	et	al.	Sentinel	lymph	node	mapping	with	GI	can-
cer.	Cancer	Metastasis	Rev	2006;25:269-277.
6.	Lee	JH,	Ryu	KW,	Kook	MC,	Lee	JY,	Kim	CG,	Choi	IJ,	et	al.	
Feasibility	of	laparoscopic	sentinel	basin	dissection	for	limited	
resection	in	early	gastric	cancer.	J	Surg	Oncol	2008;98:331-335.
7.	Park	do	J,	Kim	HH,	Park	YS,	Lee	HS,	Lee	WW,	Lee	HJ,	et	al.	
Simultaneous	indocyanine	green	and	(99m)Tc-antimony	sul-
fur	colloid-guided	laparoscopic	sentinel	basin	dissection	for	
gastric	cancer.	Ann	Surg	Oncol	2011;18:160-165.
8.	Lee	JH,	Ryu	KW,	Lee	SE,	Cho	SJ,	Lee	JY,	Kim	CG,	et	al.	Learn-
ing	curve	for	identification	of	sentinel	lymph	node	based	
on	a	cumulative	sum	analysis	in	gastric	cancer.	Dig	Surg	
2009;26:465-470.	
9.	Kitagawa	Y,	Takeuchi	H,	Takagi	Y,	Natsugoe	S,	Terashima	M,	
Murakami	N,	et	al.	Prospective	multicenter	trial	of	sentinel	
node	mapping	for	gastric	cancer.	J	Clin	Oncol	2009;27(15S):	
4518.
10.	Miyashiro	I,	Hiratuska	M,	Sasako	M,	Sano	T,	Nakamura	K,	
Nashimot	A.	Final	results	of	the	multicenter	trial	JCOG0302:	
High	false	negative	rate	and	less-accurate	intraoperative	his-
tological	examination	using	one	plane	as	serious	problem	for	
clinical	application.	2011	IGCC	proceeding	FP	18-8.
11.	http://www.clinicaltrials.gov/ct2/show/NCT01544413/Accessed 
February 28, 2012